Brief: Ascendis Pharma And Royalty Pharma Enter Into $150 Million Royalty Funding Agreement

Royalty Pharma

05/09/2023 21:43

Sept 5 (Reuters) - Ascendis Pharma A/S  A71.F :
    * ASCENDIS PHARMA AND ROYALTY PHARMA ENTER INTO $150 MILLION
ROYALTY FUNDING AGREEMENT
    * ASCENDIS PHARMA A/S - ENTERED INTO A $150 MILLION CAPPED
SYNTHETIC ROYALTY FUNDING AGREEMENT WITH ROYALTY PHARMA BASED ON
U.S. NET SKYTROFA REVENUE

Source text for Eikon:  ID:nGNX66dbRZ 
Further company coverage:  A71.F 

 ((Reuters.Briefs@thomsonreuters.com;))